Myriad Genetics Q1 Product Revenues Increase 3 Percent : vim

The company reported revenues of $164.9 million, all of which came from its molecular testing business, beating analysts' consensus expectation.

Related Keywords

Paul Diaz , Mychoice Cdx , Bracanalysis Cdx , Precise Oncology Solutions , Myriad Genetics , Wall Street , Salt Lake City Based , Trusight Oncology , Salt Lake City Based Intermountain , Myrisk Hereditary Cancer Test , Precise Tumor Molecular Profile Test ,